DK0548095T3 - Farmaceutiske præparater indeholdende superoxiddismutase fra bacillus stearothermophilus og bacilluscaldotenax - Google Patents

Farmaceutiske præparater indeholdende superoxiddismutase fra bacillus stearothermophilus og bacilluscaldotenax

Info

Publication number
DK0548095T3
DK0548095T3 DK91914597T DK91914597T DK0548095T3 DK 0548095 T3 DK0548095 T3 DK 0548095T3 DK 91914597 T DK91914597 T DK 91914597T DK 91914597 T DK91914597 T DK 91914597T DK 0548095 T3 DK0548095 T3 DK 0548095T3
Authority
DK
Denmark
Prior art keywords
bacillus
stearothermophilus
superoxide dismutase
coli
bsmnsod
Prior art date
Application number
DK91914597T
Other languages
English (en)
Inventor
Anthony Atkinson
Kevin John Bown
John Karl Brehm
Stephen Phillip Chambers
Nigel Peter Minton
Kevin John Phls Centre Fo Bown
John Karl Phls Centre Fo Brehm
Stephen Phillip Phls Chambers
Nigel Peter Phls Centre Minton
Original Assignee
Microbiological Res Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Res Authority filed Critical Microbiological Res Authority
Application granted granted Critical
Publication of DK0548095T3 publication Critical patent/DK0548095T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK91914597T 1990-08-03 1991-08-02 Farmaceutiske præparater indeholdende superoxiddismutase fra bacillus stearothermophilus og bacilluscaldotenax DK0548095T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909017037A GB9017037D0 (en) 1990-08-03 1990-08-03 Process for producing enzymes having superoxide dismutase activity,novel superoxide dismutase enzymes and novel pharmaceutical compositions comprising enzymes
PCT/GB1991/001325 WO1992002625A1 (en) 1990-08-03 1991-08-02 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax

Publications (1)

Publication Number Publication Date
DK0548095T3 true DK0548095T3 (da) 1998-08-10

Family

ID=10680104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91914597T DK0548095T3 (da) 1990-08-03 1991-08-02 Farmaceutiske præparater indeholdende superoxiddismutase fra bacillus stearothermophilus og bacilluscaldotenax

Country Status (9)

Country Link
EP (1) EP0548095B1 (da)
JP (1) JPH05508999A (da)
AT (1) ATE160586T1 (da)
AU (1) AU657695B2 (da)
CA (1) CA2088574C (da)
DE (1) DE69128286T2 (da)
DK (1) DK0548095T3 (da)
GB (1) GB9017037D0 (da)
WO (1) WO1992002625A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN283195A0 (en) * 1995-05-05 1995-06-01 Australian Water Technologies Pty Ltd Method for the detection of viable cryptosporidium parvum cells
DE102007010785A1 (de) * 2007-03-02 2008-09-04 Henkel Ag & Co. Kgaa Verwendung von Superoxid-Dismutasen in Wasch- und Reinigungsmitteln
CN116496996B (zh) * 2023-06-14 2024-01-23 河北纳科生物科技有限公司 一种重组大肠杆菌生产sod的发酵工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816685A (ja) * 1981-07-22 1983-01-31 Takeda Chem Ind Ltd 固定化酵素，その製造法および製剤
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
JPH0653670B2 (ja) * 1985-10-28 1994-07-20 日研フ−ド株式会社 化学療法剤の副作用低減化剤
JPS63245671A (ja) * 1987-03-31 1988-10-12 Kanebo Ltd 修飾ス−パ−オキシドジスムタ−ゼ
JPH0757193B2 (ja) * 1987-08-05 1995-06-21 宇部興産株式会社 改良プロモ−タ−、これを有するベクタ−、このベクタ−を有するプラスミド及びこのプラスミドを有する宿主菌

Also Published As

Publication number Publication date
ATE160586T1 (de) 1997-12-15
EP0548095A1 (en) 1993-06-30
AU657695B2 (en) 1995-03-23
EP0548095B1 (en) 1997-11-26
WO1992002625A1 (en) 1992-02-20
DE69128286D1 (de) 1998-01-08
AU8331191A (en) 1992-03-02
CA2088574C (en) 2002-12-10
GB9017037D0 (en) 1990-09-19
DE69128286T2 (de) 1998-03-19
JPH05508999A (ja) 1993-12-16
CA2088574A1 (en) 1992-02-04

Similar Documents

Publication Publication Date Title
BRUCHHAUS et al. Removal of hydrogen peroxide by the 29 kDa protein of Entamoeba histolytica
AU5222498A (en) Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
EP0150126A3 (en) The synthesis of protein with an identification peptide
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
DE69109109D1 (de) Ubiquitinspezifische protease.
HK1007435A1 (en) Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms
KR940703860A (ko) 신규한 사람 쿠니즈형 프로테아제 저해제 및 그의 변이체(a novel human kunitz-type protease inhibitor and variants thereof)
Fujii et al. Purification and characterization of rho-crystallin from Japanese common bullfrog lens.
Sha et al. Brucella abortus catalase is a periplasmic protein lacking a standard signal sequence
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
Hata et al. Roles for Proline-Rich Regions of p47phoxand p67phoxin the Phagocyte NADPH Oxidase Activationin Vitro
NL300046I2 (nl) Eiwit met uraat oxidase activiteit, recombinant gen dat hiervoor codeert, expressievector, micro-organismen en getransformeerde cellen.
DK0548095T3 (da) Farmaceutiske præparater indeholdende superoxiddismutase fra bacillus stearothermophilus og bacilluscaldotenax
IE59498B1 (en) Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
ES2076152T3 (es) Definicion y estructura de genes para proteasa a y proteasa b procedente de streptomices griseus.
EP0195680A3 (en) The synthesis of protein with an identification peptide
US5246847A (en) Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
HUP0104996A2 (hu) Enzimes oxidatív dezaminálási eljárás
NZ500844A (en) Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
Schlatter et al. The primary structure of the psychrophilic lactate dehydrogenase from Bacillus psychrosaccharolyticus
Furlong et al. The large subunit of herpes simplex virus type 1 ribonucleotide reductase: expression in Escherichia coli and purification
Gonzalez-Villaseñor et al. A multilocus system for studying tissue and subcellular specialization. The three NADP-dependent isocitrate dehydrogenase isozymes of the fish Fundulus heteroclitus.
PACE et al. The nature of the multiple forms of bovine thiol: protein disulfide oxidoreductase
Hernandez-Saavedra et al. Thiol-sensitive mutant forms of human SOD2, L60F, and I58T: the role of Cys140